389 related articles for article (PubMed ID: 19966810)
21. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.
Ebert BL; Pretz J; Bosco J; Chang CY; Tamayo P; Galili N; Raza A; Root DE; Attar E; Ellis SR; Golub TR
Nature; 2008 Jan; 451(7176):335-9. PubMed ID: 18202658
[TBL] [Abstract][Full Text] [Related]
22. Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.
Lehmann S; O'Kelly J; Raynaud S; Funk SE; Sage EH; Koeffler HP
Leukemia; 2007 Sep; 21(9):1931-6. PubMed ID: 17625608
[TBL] [Abstract][Full Text] [Related]
23. Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q.
Panagiota V; Meggendorfer M; Kubasch AS; Gabdoulline R; Krönke J; Mies A; Shahswar R; Kandziora C; Klement P; Schiller J; Göhring G; Haferlach C; Ganster C; Shirneshan K; Gutermuth A; Thiede C; Germing U; Schroeder T; Kobbe G; Klesse S; Koenecke C; Schlegelberger B; Kröger N; Haase D; Döhner K; Sperr WR; Valent P; Ganser A; Thol F; Haferlach T; Platzbecker U; Heuser M
Am J Hematol; 2021 Jun; 96(6):E207-E210. PubMed ID: 33725366
[No Abstract] [Full Text] [Related]
24. Specificity of haematological indicators for '5q- syndrome' in patients with myelodysplastic syndromes.
Teerenhovi L
Eur J Haematol; 1987 Oct; 39(4):326-30. PubMed ID: 3691757
[TBL] [Abstract][Full Text] [Related]
25. Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer.
Ebert BL
Leukemia; 2009 Jul; 23(7):1252-6. PubMed ID: 19322210
[TBL] [Abstract][Full Text] [Related]
26. Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study.
Garderet L; Kobari L; Mazurier C; De Witte C; Giarratana MC; Pérot C; Gorin NC; Lapillonne H; Douay L
Haematologica; 2010 Mar; 95(3):398-405. PubMed ID: 19815832
[TBL] [Abstract][Full Text] [Related]
27. L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.
Payne EM; Virgilio M; Narla A; Sun H; Levine M; Paw BH; Berliner N; Look AT; Ebert BL; Khanna-Gupta A
Blood; 2012 Sep; 120(11):2214-24. PubMed ID: 22734070
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.
Chen TH; Kambal A; Krysiak K; Walshauser MA; Raju G; Tibbitts JF; Walter MJ
Blood; 2011 Feb; 117(5):1530-9. PubMed ID: 21123823
[TBL] [Abstract][Full Text] [Related]
29. Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion.
Wei S; Chen X; McGraw K; Zhang L; Komrokji R; Clark J; Caceres G; Billingsley D; Sokol L; Lancet J; Fortenbery N; Zhou J; Eksioglu EA; Sallman D; Wang H; Epling-Burnette PK; Djeu J; Sekeres M; Maciejewski JP; List A
Oncogene; 2013 Feb; 32(9):1110-20. PubMed ID: 22525275
[TBL] [Abstract][Full Text] [Related]
30. Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome.
Vlachos A; Farrar JE; Atsidaftos E; Muir E; Narla A; Markello TC; Singh SA; Landowski M; Gazda HT; Blanc L; Liu JM; Ellis SR; Arceci RJ; Ebert BL; Bodine DM; Lipton JM
Blood; 2013 Oct; 122(14):2487-90. PubMed ID: 23943650
[TBL] [Abstract][Full Text] [Related]
31. Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis.
Keel SB; Phelps S; Sabo KM; O'Leary MN; Kirn-Safran CB; Abkowitz JL
Exp Hematol; 2012 Apr; 40(4):290-4. PubMed ID: 22198155
[TBL] [Abstract][Full Text] [Related]
32. Van-den Berghe's 5q- syndrome in 2008.
Mohamedali A; Mufti GJ
Br J Haematol; 2009 Jan; 144(2):157-68. PubMed ID: 19016715
[TBL] [Abstract][Full Text] [Related]
33. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
[TBL] [Abstract][Full Text] [Related]
34. A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q - myelodysplastic syndromes.
Voutsadakis IA; Cairoli A
Leuk Lymphoma; 2012 May; 53(5):779-88. PubMed ID: 21955212
[TBL] [Abstract][Full Text] [Related]
35. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
[TBL] [Abstract][Full Text] [Related]
36. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.
Starczynowski DT; Kuchenbauer F; Argiropoulos B; Sung S; Morin R; Muranyi A; Hirst M; Hogge D; Marra M; Wells RA; Buckstein R; Lam W; Humphries RK; Karsan A
Nat Med; 2010 Jan; 16(1):49-58. PubMed ID: 19898489
[TBL] [Abstract][Full Text] [Related]
37. Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc.
Stoddart A; Wang J; Fernald AA; Karrison T; Anastasi J; Le Beau MM
Blood; 2014 Jan; 123(2):228-38. PubMed ID: 24264229
[TBL] [Abstract][Full Text] [Related]
38. Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes: the 5q-syndrome, a distinct entity.
Mahmood T; Robinson WA; Hamstra RD; Wallner SF
Am J Med; 1979 Jun; 66(6):946-50. PubMed ID: 453227
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.
Nilsson L; Astrand-Grundström I; Arvidsson I; Jacobsson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2000 Sep; 96(6):2012-21. PubMed ID: 10979941
[TBL] [Abstract][Full Text] [Related]
40. The 5q--syndrome: an underdiagnosed form of macrocytic anaemia.
Tinegate H; Gaunt L; Hamilton PJ
Br J Haematol; 1983 May; 54(1):103-10. PubMed ID: 6849830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
